enVVeno Medical (NVNO)
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the...
- Open
- 11.360
- High
- 11.360
- Low
- 10.530
- Prev. Close
- 11.470
- Volume
- 42.20K
- Turnover
- 462.76K
- Avg Price
- 10.965
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 7.24%
- 52wk High
- 35.700
- Volume Ratio
- 0.53
- Turnover Ratio
- 8.90%
enVVeno Medical Analyst Rating
View moreForecast & Rating
Jul 6, 2026Price forecast
$30.00173.22%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Aug 27 at 01:03 PM
enVVeno Medical wins FDA IDE approval for enVVe pivotal trial in deep venous insufficiency
- StockTitan · Aug 4 at 04:46 AM
Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments | NVNO Stock News
- PUBT · Jul 30 at 08:25 PM
enVVeno net loss narrows 46% to $3.6 million in Q2 FY26
- TradingView · Jul 23 at 11:01 AM
NVNO Q2'26 Earnings: revenue estimate is 0 USD
